NCT00206401View on ClinicalTrials.gov

Lantus in the Treatment of Type 1 Diabetes Children

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

October 31, 2006

Conditions
Type 1 Diabetes
Interventions
DRUG

Lantus and short acting analogs Vs NPH and short acting analogs

Trial Locations (1)

77030

Texas Children's Hospital, Houston

All Listed Sponsors
lead

Baylor College of Medicine

OTHER

NCT00206401 - Lantus in the Treatment of Type 1 Diabetes Children | Biotech Hunter | Biotech Hunter